Jill M. Weimer, Ph.D.
Affiliations: | 2006 | University of Rochester, Rochester, NY |
Area:
Neuroscience BiologyGoogle:
"Jill Weimer"Mean distance: 17.71 (cluster 11)
Parents
Sign in to add mentorEva Anton | grad student | |||
Howard J. Federoff | grad student | 2006 | Rochester | |
(Systematic analysis of cellular and behavioural changes in the Cln3-/- mouse model of Batten disease.) |
Children
Sign in to add traineeJon J Brudvig | grad student | University of South Dakota | |
Jacob T. Cain | grad student |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Meyerink BL, Karia KS, Rechtzigel MJ, et al. (2024) Mutation in leads to early motor dysfunction and widespread aberrant axon terminals in a beta-propeller protein associated neurodegeneration (BPAN) patient-inspired mouse model. Biorxiv : the Preprint Server For Biology |
Han J, Chear S, Talbot J, et al. (2024) Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease. Investigative Ophthalmology & Visual Science. 65: 23 |
Byrne BJ, Parenti G, Schoser B, et al. (2024) Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. Frontiers in Neurology. 15: 1451512 |
Han J, Chear S, Talbot J, et al. (2024) Genetic and cellular basis of impaired phagocytosis and photoreceptor degeneration in CLN3 disease. Biorxiv : the Preprint Server For Biology |
Brudvig JJ, Tuske S, Castelli J, et al. (2024) Comments on: Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice. The Journal of Pharmacology and Experimental Therapeutics. 389: 310-312 |
Schulz A, Patel N, Brudvig JJ, et al. (2024) The parent and family impact of CLN3 disease: an observational survey-based study. Orphanet Journal of Rare Diseases. 19: 125 |
Leppert HG, Anderson JT, Timm KJ, et al. (2023) Sortilin inhibition treats multiple neurodegenerative lysosomal storage disorders. Biorxiv : the Preprint Server For Biology |
Centa JL, Stratton MP, Pratt MA, et al. (2023) Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach. Molecular Therapy. Nucleic Acids. 33: 15-27 |
Swier VJ, White KA, Johnson TB, et al. (2023) A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes. Disease Models & Mechanisms |
Johnson TB, Brudvig JJ, Likhite S, et al. (2023) Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Frontiers in Genetics. 14: 1118649 |